+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Application of allogeneic mesenchymal stem cells in complex patients treatment with ulcerative colitis



Application of allogeneic mesenchymal stem cells in complex patients treatment with ulcerative colitis



Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(5): 4-12



Systemic transplantation of mesenchymal stem cells (MSC) is known to promote reparative process in a number of tissue damage as well as mucous healing one. It provided the basis for our study which was aimed to the effect of systemic transplantation of allogenic MSC (intravenous transfusion) in complex therapy of patients with Ulcerative Colitis.

(PDF emailed within 1 workday: $29.90)

Accession: 051607975

Download citation: RISBibTeXText

PMID: 20205326



Related references

The successful application of allogeneic mesenchymal stem cells in a patient with ulcerative colitis. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(4): 112-115, 2010

Pharmacoeconomic benefits of patients with ulcerative colitis treatment with help of mesenchymal stem cells. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(3): 51-59, 2010

Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation. Eksperimental'naia i Klinicheskaia Gastroenterologiia 11): 3-15, 2011

Transplantation of allogeneic mesenchymal stem cells from the bone marrow increases duration of remission and reduces the risk of ulcerative colitis relapse. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(3): 5-10, 2010

Age as a prognostic factor in the treatment effectiveness of patients with ulcerative colitis with help of mesenchymal stromal cells. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2011(12): 3-9, 2011

Use of mesenchymal stem cells in the combination therapy of ulcerative colitis. Terapevticheskii Arkhiv 88(2): 44-48, 2016

Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. Blood Cells, Molecules and Diseases 40(1): 25-32, 2007

Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. Oncotarget 7(11): 11899-11912, 2017

Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis. Stem Cell Research and Therapy 6: 263, 2016

Inhibition of in vitro cytotoxicity of lymphocytes from patients with ulcerative colitis and granulomatous colitis for allogeneic colonic epithelial cells using horse anti-human thymus serum. Gastroenterology 54(2): 227-231, 1968

Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis. Digestive Diseases and Sciences 60(7): 1948-1957, 2015

Origin of mesenchymal stem cells in bone marrow of patients after allogeneic stem cell transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14(2): 322-326, 2006

Adipose-Derived Mesenchymal Stem Cells Ameliorate Ulcerative Colitis Through miR-1236 Negatively Regulating the Expression of Retinoid-Related Orphan Receptor Gamma. Dna and Cell Biology 34(10): 618-625, 2016

Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. Stem Cell Reviews 10(3): 351-375, 2014

Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9(+) cancer stem cells in ulcerative colitis-related cancer. Clinics and Research in Hepatology and Gastroenterology 40(4): 487-493, 2018